New attack waves from the 'PhantomRaven' supply-chain campaign are hitting the npm registry, with dozens of malicious packages that exfiltrate sensitive data from JavaScript developers.

Quadratic regression is a classical machine learning technique to predict a single numeric value. Quadratic regression is an extension of basic linear regression. Quadratic regression can deal with ...

Using a tool to solve a protein's structure, for most researchers in the world of structural biology and computational chemistry, is not unlike using the Rosetta Stone to unlock the secrets of ancient ...

We introduce VeriStruct, a novel framework that extends AI-assisted automated verification from single functions to more complex data structure modules in Verus. VeriStruct employs a planner module to ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. Drawing on our experience, this Viewpoint highlights four ...

Abstract: Data aggregation is essential in near-ground long chain sensing networks, as it ensures data freshness and stability while extending communication range through path planning and traffic ...

This package is intended to speed up the communication time between different JavaScript threads by exposing data structures that internally use a SharedArrayBuffer to store all required information.

In his 1960 book Theory and Design in the First Machine Age, the critic and historian Reyner Banham presciently noted a growing chasm between technological change and the capacity of designers to ...

Graduate School of Pharmaceutical Sciences, Keio University, Minato-ku, Tokyo 105-8512, Japan Molecular and Cellular Epigenetics Laboratory, Graduate School of Medical Life Science, Yokohama City ...

Structure Therapeutics' stock has declined over 40% since last year, but its differentiated technology platform and promising drug pipeline still support a "Buy" rating. Structure's lead candidate, ...